Research Roundup: Vaccine Efficacy in Rheumatoid Arthritis
Vaccine efficacy in RA, biosimilar safety and the danger of steroid injections for knee osteoarthritis top this week's research roundup. In this slideshow, we feature these and other recent research findings from the key journals.
Biosimilar Proves to be OK for Switching
Clinical trial shows that switching from the infliximab originator to its biosimilar does not compromise safety or effectiveness of treatment.
Is it Lyme arthritis or JIA?
A Lyme arthritis diagnosis requires a two-step testing approach. False positives are complex and common.
Anti-NGF Fulranumab Effective for Pain Control in Osteoarthritis
Despite monthly dosing regimen and long half-life of fulranumab, patients experienced pain relief within a short period of time.
Methotrexate-Corticosteroid Combo Therapy Tested in JIA
The combination therapy only slightly outperformed standard corticosteroid treatment in a trial for juvenile idiopathic arthritis.
RA, Methotrexate and Alcohol May Mix Well, to a Degree
The combination of alcohol and methotrexate is generally frowned upon, but a new study suggests alcohol in small quantities may be OK.
Methotrexate Should be First in Rheumatoid Arthritis, EULAR Guidelines Say
EULAR's new rheumatoid arthritis treatment guidelines are comprehensive including recommendations for the use of everything from methotrexate to biosimilars.
By clicking Accept, you agree to become a member of the UBM Medica Community.